Literature DB >> 25868867

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.

D Cragun1, D Bonner, J Kim, M R Akbari, S A Narod, A Gomez-Fuego, J D Garcia, S T Vadaparampil, Tuya Pal.   

Abstract

Concerns about the potential for genomic advances to increase health disparities have been raised. Thus, it is important to assess referral and uptake of genetic counseling (GC) and testing in minority populations at high risk for hereditary breast and ovarian cancer (HBOC). Black women diagnosed with invasive breast cancer ≤age 50 in 2009-2012 were recruited through the Florida State Cancer Registry 6-18 months following diagnosis and completed a baseline questionnaire. Summary statistics, Chi-square tests, and path modeling were conducted to examine which demographic and clinical variables were associated with referral and access to genetic services. Of the 440 participants, all met national criteria for GC, yet only 224 (51 %) were referred for or received GC and/or HBOC testing. Variables most strongly associated with healthcare provider referral for GC included having a college education (OR 2.1), diagnosis at or below age 45 (OR 2.0), and triple negative tumor receptor status (OR 1.7). The strongest association with receipt of GC and/or HBOC testing was healthcare provider referral (OR 7.9), followed by private health insurance at diagnosis (OR 2.8), and household income greater than $35,000 in the year prior to diagnosis (OR 2.0). Study findings suggest efforts are needed to improve genetic services access among a population-based sample of high-risk Black women. These results indicate that socioeconomic factors and physician referral patterns contribute to disparities in access to genetic services within this underserved minority population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25868867      PMCID: PMC4503247          DOI: 10.1007/s10549-015-3374-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  34 in total

1.  Marketing genetic tests: empowerment or snake oil?

Authors:  Deborah J Bowen; Kathryn M Battuello; Monique Raats
Journal:  Health Educ Behav       Date:  2005-10

Review 2.  The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues.

Authors:  Stuart Hogarth; Gail Javitt; David Melzer
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

3.  Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations.

Authors:  Hayley S Thompson; Katarina Sussner; Marc D Schwartz; Tiffany Edwards; Andrea Forman; Lina Jandorf; Karen Brown; Dana H Bovbjerg; Heiddis B Valdimarsdottir
Journal:  Genet Test Mol Biomarkers       Date:  2012-10-11

4.  Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.

Authors:  Bronson D Riley; Julie O Culver; Cécile Skrzynia; Leigha A Senter; June A Peters; Josephine W Costalas; Faith Callif-Daley; Sherry C Grumet; Katherine S Hunt; Rebecca S Nagy; Wendy C McKinnon; Nancie M Petrucelli; Robin L Bennett; Angela M Trepanier
Journal:  J Genet Couns       Date:  2011-12-02       Impact factor: 2.537

5.  Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

Authors:  Nasim Mavaddat; Susan Peock; Debra Frost; Steve Ellis; Radka Platte; Elena Fineberg; D Gareth Evans; Louise Izatt; Rosalind A Eeles; Julian Adlard; Rosemarie Davidson; Diana Eccles; Trevor Cole; Jackie Cook; Carole Brewer; Marc Tischkowitz; Fiona Douglas; Shirley Hodgson; Lisa Walker; Mary E Porteous; Patrick J Morrison; Lucy E Side; M John Kennedy; Catherine Houghton; Alan Donaldson; Mark T Rogers; Huw Dorkins; Zosia Miedzybrodzka; Helen Gregory; Jacqueline Eason; Julian Barwell; Emma McCann; Alex Murray; Antonis C Antoniou; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2013-04-29       Impact factor: 13.506

6.  Reading between the lines: direct-to-consumer advertising of genetic testing in the USA.

Authors:  S C Hull; K Prasad
Journal:  Reprod Health Matters       Date:  2001-11

7.  Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-02-18       Impact factor: 25.391

8.  Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.

Authors:  Anne Marie McCarthy; Mirar Bristol; Tracey Fredricks; Lache Wilkins; Irene Roelfsema; Kaijun Liao; Judy A Shea; Peter Groeneveld; Susan M Domchek; Katrina Armstrong
Journal:  Cancer       Date:  2013-07-16       Impact factor: 6.860

9.  Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.

Authors:  Mary B Daly; Robert Pilarski; Jennifer E Axilbund; Saundra S Buys; Beth Crawford; Susan Friedman; Judy E Garber; Carolyn Horton; Virginia Kaklamani; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer Litton; Lisa Madlensky; P Kelly Marcom; Sofia D Merajver; Kenneth Offit; Tuya Pal; Boris Pasche; Gwen Reiser; Kristen Mahoney Shannon; Elizabeth Swisher; Nicoleta C Voian; Jeffrey N Weitzel; Alison Whelan; Georgia L Wiesner; Mary A Dwyer; Rashmi Kumar
Journal:  J Natl Compr Canc Netw       Date:  2014-09       Impact factor: 11.908

10.  Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling.

Authors:  Grace Wang; Mary S Beattie; Ninez A Ponce; Kathryn A Phillips
Journal:  Genet Med       Date:  2011-12       Impact factor: 8.822

View more
  38 in total

1.  A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.

Authors:  Erica M Bednar; Holly D Oakley; Charlotte C Sun; Catherine C Burke; Mark F Munsell; Shannon N Westin; Karen H Lu
Journal:  Gynecol Oncol       Date:  2017-06-10       Impact factor: 5.482

Review 2.  Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.

Authors:  Christina D Williams; Alyssa Jasmine Bullard; Meghan O'Leary; Reana Thomas; Thomas S Redding; Karen Goldstein
Journal:  J Racial Ethn Health Disparities       Date:  2019-04-08

3.  Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.

Authors:  Megan C Roberts; George A Mensah; Muin J Khoury
Journal:  Ethn Dis       Date:  2019-02-21       Impact factor: 1.847

4.  Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.

Authors:  Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters
Journal:  Contemp Clin Trials       Date:  2018-09-18       Impact factor: 2.226

5.  A randomized controlled intervention to promote readiness to genetic counseling for breast cancer survivors.

Authors:  Monica L Kasting; Claire C Conley; Aasha I Hoogland; Courtney L Scherr; Jongphil Kim; Ram Thapa; Maija Reblin; Cathy D Meade; M Catherine Lee; Tuya Pal; Gwendolyn P Quinn; Susan T Vadaparampil
Journal:  Psychooncology       Date:  2019-04-11       Impact factor: 3.894

6.  Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Allison W Kurian; R Kate Kelley; Patricia A Deverka; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2017-02-10       Impact factor: 11.908

7.  Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.

Authors:  Kristina G Flores; Laurie E Steffen; Christopher J McLouth; Belinda E Vicuña; Amanda Gammon; Wendy Kohlmann; Lucretia Vigil; Zoneddy R Dayao; Melanie E Royce; Anita Y Kinney
Journal:  J Genet Couns       Date:  2016-08-06       Impact factor: 2.537

8.  Effective communication in the era of precision medicine: A pilot intervention with low health literacy patients to improve genetic counseling communication.

Authors:  Galen Joseph; Robin Lee; Rena J Pasick; Claudia Guerra; Dean Schillinger; Sara Rubin
Journal:  Eur J Med Genet       Date:  2018-12-13       Impact factor: 2.708

9.  Baseline knowledge and receptiveness to genetic testing for hereditary breast and ovarian cancer syndromes in Chinese high-risk females.

Authors:  Annie Tsz-Wai Chu; Desiree Man-Sik Tse; Dacita To Ki Suen; Ava Kwong
Journal:  J Community Genet       Date:  2021-04-30

10.  Uptake of genetic testing for germline BRCA1/2 pathogenic variants in a predominantly Hispanic population.

Authors:  Julia E McGuinness; Meghna S Trivedi; Thomas Silverman; Awilda Marte; Jennie Mata; Rita Kukafka; Katherine D Crew
Journal:  Cancer Genet       Date:  2019-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.